Niagen Bioscience Selects Evotec as CRO to Advance IND-Enabling Development for NB4168 in Ataxia Telangiectasia
South Korean CRO BNP Lab Partners With The Invention Lab to Co-Invest in Biotech Startups From Discovery to Scale-Up
Clean Cells Acquires Mass Spectrometry CRO Anaquant to Deliver End-to-End Protein Characterization From Early Development Through GMP Release Read more
ICON Partners With Anthropic in Multi-Year Collaboration to Deploy Claude’s Frontier AI Across the Clinical Trial Lifecycle Read more
Quartesian Co-Founders Reunite to Launch Acrosian as a Purpose-Built AI-Native Biometrics CRO Read more
HoneyNaps Registers as CRO to Expand AI-Powered Sleep Analytics Across Global Pharmaceutical and Medical Device Trials Read more
GCCL and GemPharmatech Sign MOU to Deliver Integrated Preclinical-to-Clinical CRO Services Across Korea, U.S., and China Read more
Crown Bioscience Joins C-Path’s NAMs Developer Coalition to Advance Regulatory Acceptance of Human-Relevant CRO Preclinical Models Read more
CellCarta Launches Global Digital Pathology and AI Consortium to Give CRO Sponsors Platform-Agnostic Access to Leading AI Innovators Read more
HKeyBio Launches HKEY-AI-NAM-Bridge™ 1.0 to Close Evidence Gaps Between AI, NAMs, and In Vivo CRO Validation Read more
NetraMark Signs First CRO-Channelled Contract to Apply NetraAI Platform to Phase 2 Neurodegeneration Trial Data Read more
ProPharma Deploys Proprietary AI Capability to Accelerate ANDA Submission Development for Regulatory CRO Clients Read more
CNR Research Posts Record CRO Order Backlog as Overseas Contracts and AI Platform Transition Drive Growth Read more
Caidya and Simbec-Orion Combine to Create Integrated Specialty CRO From First-in-Human Through Registration Read more
ICON Reports $3.3B in Gross Bookings and 1.42x Net Book-to-Bill in Q1 2026 as CRO Backlog Reaches $22.7B Read more
Avance Clinical Expands CRO Footprint Into Singapore, Malaysia, and Mainland China to Build Six-Market Asia Pacific Platform Read more
Specialist CRO Engaged to Manage European Human Study Operations and Regulatory Submissions for Polyrizon’s NASARIX™ Allergy Blocker Read more
Pelago Bioscience Acquires RG Discovery to Deliver Fully Integrated Biology and Chemistry Drug Discovery CRO Platform Read more
FibroFind Appoints Co-Founder Lee Borthwick as CEO as Preclinical CRO Doubles in Size and Expands Leadership Team Read more
Aurisco Pharmaceutical Becomes First Generic Oligonucleotide API Manufacturer to Pass USFDA Inspection